Metro Healthcare Indonesia Tbk. vs Kian Santang Muliatama Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.23T, 108.5K 24h volume), while Kian Santang Muliatama Tbk. trades at Rp214 (market cap 312.28B, 3.94M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 45.6× Kian Santang Muliatama Tbk.'s market cap, and Kian Santang Muliatama Tbk. is more actively traded (3.94M versus 108.5K). Which is the better fit depends on your goals.
| CARE | RGAS | |
|---|---|---|
Market Cap | 14.23T | 312.28B |
Volume | 108.5K | 3.94M |
Lot | 1.09K | 39.45K |
Turnover | 46.35M | 834.26M |
Average Price | 427.16 | 211.49 |
Value | 46.35M | 834.26M |
Indicative Equilibrium Price | 428 | 214 |
Indicative Equilibrium Volume | 400 | 179.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →